TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/22 16:36 | 5/11/22 | TWST | Twist Bioscience Corp | DE | Health | BioPrd | Biological Products, (No Diag | Barthelemy Nicolas | CA | D | P | 250 | 29.25 | 0 | 9 | 159 | 14 | D | |||||||||||||||
12/22/20 20:20 | 12/22/20 | MASS | 908 Devices Inc. | DE | Electr | LabEq | Measuring & Controlling Devic | Barthelemy Nicolas | MA | D | P.d | 280 | 20.00 | 0 | 14 | 72 | 34 | M | |||||||||||||||
3/10/20 18:59 | 3/6/20 | FLDM | Fluidigm Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Barthelemy Nicolas | CA | D | P | 244 | 3.05 | 0 | 80 | 115 | 149 | I | |||||||||||||||
2/18/20 20:33 | 2/13/20 | FLDM | Fluidigm Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Barthelemy Nicolas | CA | D | P | 45 | 3.64 | 0 | 12 | 21 | 69 | I | |||||||||||||||
8/8/06 18:28 | 8/7/06 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Barthelemy Nicolas | CA | O | SVP BioP | P | 152 | 56.24 | 0 | 3 | 48 | 8 | D | ||||||||||||||
8/9/04 20:34 | 8/6/04 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Barthelemy Nicolas | CA | O | SVP Ope | P | 24 | 47.35 | 0 | 1 | 5 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |